Jeffrey S. Heier

Chief Scientific Officer, Ocular Therapeutix, Inc

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Oct 2, 2026

Companies

Ocular Therapeutix, IncChief Scientific Officer −$0.3M

Trades

OCUL Sold 10,869 shares at $7.05 · planned $0.1M Oct 2

OCUL Sold 3,296 shares at $10.78 · planned $0.0M Aug 24

OCUL Sold 3,018 shares at $8.20 · planned $0.0M May 26

OCUL Sold 3,057 shares at $8.28 · planned $0.0M Feb 23

OCUL Sold 3,469 shares at $12.04 · planned $0.0M Nov 24

OCUL Sold 10,502 shares at $11.04 · planned $0.1M Oct 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.